Business Wire

Protembis Announces Formation of New Scientific Advisory Board Comprised of World-Renowned Structural Heart Experts

Share

Protembis, a privately-held emerging cardiovascular medical device company, announced today the establishment of a Scientific Advisory Board (SAB) to provide objective advice and contribute to the strategic plans of the company. Specifically, the SAB will provide overarching scientific and clinical strategic guidance, advise on emerging trends and opportunities, and provide expert counsel on scientific and clinical matters.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250317149296/en/

The SAB will be comprised of four internationally recognized interventional cardiologists, who have made significant contributions to the understanding of the role for cerebral embolic protection (CEP) in transcatheter aortic valve replacement (TAVR): Dr Martin Leon MD, Dr Anita Asgar MD, Dr Samir Kapadia MD, and Dr Nicolas van Mieghem MD.

The SAB is chaired by Dr Martin Leon, Professor of Medicine at New York’s Columbia University Irving Medical Center and Chief Innovation Officer and the Director of the Cardiovascular Data Science Center for the Division of Cardiology. Dr. Leon has played a pivotal role in shaping the field of interventional cardiovascular medicine through his involvement in over 50 clinical trials. He has co-authored over 1550 publications and has directed or co-directed over 100 international educational programs focused on interventional cardiology. Dr. Leon's significant contributions to the medical community have been recognized with 10 international career achievement awards, and he has been awarded an honorary degree from the University of Athens.

“I have been impressed by the Protembis management and their innovative US pivotal clinical trial design that utilizes MRI endpoints. I am looking forward to collaborating with the other members of the SAB to advise on the technology’s future evolution as the field of TAVR expands into lower risk, asymptomatic, and younger patients,” said SAB Chair Dr Martin Leon.

Having recently moved from the Montreal Institute of Cardiology where she was medical director of the structural heart program, Dr Anita Asgar is an associate professor and the medical director for structural and interventional cardiology at Northwestern Medicine in Evanston/Chicago, USA. She has published and co-authored almost 200 scientific papers in peer-reviewed journals. Her research interests include the treatment and management of valvular heart disease and cost-effectiveness analyses.

Dr Samir Kapadia is chairman of cardiology in the Robert and Suzanne Tomsich Department of Cardiovascular Medicine in Cleveland. He is the author of more than 80 book chapters in medical textbooks on his specialty interests, and he has authored more than 800 articles in peer reviewed medical journals on his clinical experience. He is editor in chief for the Textbook of Interventional Cardiology. Dr Kapadia has been instrumental in the design and execution of the seminal CEP trials as the Co-Principal Investigator of the Sentinel IDE trial (Boston Scientific, Marlborough, MA, USA) and Principal Investigator of the PROTECTED TAVR Trial. Dr Kapadia is a fellow of the American College of Cardiology, European Society of Cardiology, Society of Vascular Medicine, and a member of the American Heart Association and Society of Thoracic Surgery.

Dr Nicolas Van Mieghem is a professor of medicine and the director of interventional cardiology at the Thoraxcenter Erasmus University Medical Center in Rotterdam. He has published and co-authored over 500 scientific papers in peer-reviewed journals. He was the Principal Investigator of the MISTRAL-C European Trial of the Sentinel™ device and has been author or co-author on almost 30 publications specifically in the field of CEP. He is a principal investigator and steering committee member in multiple ongoing international trials evaluating various coronary and transcatheter valve technologies. Dr Van Mieghem is a fellow of the European Society of Cardiology and the American College of Cardiology.

“We are pleased to announce the creation of this SAB with such a roster of global recognized thought leaders,” said Protembis Co-Chief Executive Officers Karl von Mangoldt and Conrad Rasmus. “To be able to cooperate closely with the members and to benefit from their extensive clinical and strategic knowledge is a privilege. Their guidance will be critical as we map our strategic path forward.”

Protembis is currently enrolling patients in the PROTEMBO Pivotal IDE Trial (NCT05873816), which aims to show that the ProtEmbo® System is superior to contemporary practice in reducing new cerebral lesion volume when assessed by Diffusion-Weighted MRI. The novel trial randomizes ProtEmbo against a hybrid control group: half receiving no CEP and half receiving the Sentinel™ device. The trial is led by Dr Roxana Mehran (Mount Sinai, NY, USA) as the Chair of the Study Executive Committee, with Dr Susheel Kodali (New York Presbyterian Hospital, NY, USA), Dr Raj Makkar (Cedars Sinai, Los Angeles, CA, USA) and Dr Stephan Haussig (Herzzentrum, Dresden, Germany), as the Global Co-Principal Investigators.

About Protembis

Protembis is a privately-held emerging medical device company that has developed the ProtEmbo® Cerebral Protection System. The company strives to provide a simple and reliable solution to protect patients from brain injury during left-sided heart procedures, improving patient quality of life and reducing overall healthcare costs associated with brain injury. The ProtEmbo® System is currently undergoing clinical investigations.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250317149296/en/

Contacts

Protembis GmbH
Conrad Rasmus & Karl von Mangoldt
Co-CEOs
+49(0)241 9903 3622
management[at]protembis.com
www.protembis.com -
https://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww.protembis.c
om&esheet=54224569&newsitemid=20250317149296&lan=en-US&anchor=www.protembis.com&
index=1&md5=2f0ec091e7835596da2572d3789cf52b

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

www.businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

TXOne Networks Simplifies OT Security with Major Update to Endpoint Solution, Stellar18.3.2025 17:00:00 EET | Press release

TXOne Networks, a leader in Cyber-Physical Systems (CPS) security, announced Version 3.2 of its Stellar solution, further enhancing its capabilities from endpoint protection to more comprehensive detection and response in operational technology (OT) environments. Stellar simplifies the journey into threat hunting and detection while overcoming the limitations of traditional information technology (IT) endpoint detection and response (EDR) solutions, which can disrupt OT operations and productivity. Purpose-built for OT environments, Stellar ensures effective security without compromising system stability. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250318210570/en/ “We have observed that alert fatigue, which is common to EDR solutions, can be even more severe in OT security, with security teams feeling overwhelmed by warnings due to the lack of contextual information about OT devices,” said Dr. Terence Liu, Chief Executiv

Laserfiche Announces 2025 Run Smarter® Award Winners18.3.2025 16:00:00 EET | Press release

Laserfiche — a leading enterprise platform that helps organizations manage their most critical content and workflows — today announced the winners of the 2025 Laserfiche Run Smarter® Awards. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250318932755/en/ The awards honor individuals and organizations that yield exceptional business results using Laserfiche. From a state department that revolutionized how it protects the environment to an insurance agency that leapt into action after a hurricane: The winners enhance productivity, foster innovative processes and improve lives with Laserfiche technology. “These honorees are champions of the employee and customer experience,” said Karl Chan, CEO of Laserfiche. “They are leading their industries in transforming how they work using Laserfiche. We are delighted to celebrate their remarkable achievements.” Congratulations to the 2025 Run Smarter Award winners: Angela Goerner, direct

Andersen Global Broadens Reach in Bangladesh with Edge Research18.3.2025 15:30:00 EET | Press release

Andersen Global further expands into Bangladesh through a Collaboration Agreement with valuation and research firm Edge Research, further solidifying its presence in South Asia. Founded in 2017 and based in Dhaka, Edge Research focuses on corporate valuation, due diligence, transaction advisory, and financial analysis for both the public and private sectors. The firm’s expertise spans multiple asset classes and domains, supported by a deep understanding of the Bangladesh market. With a team experienced in working with multinational companies, global banks, and foreign fund managers, Edge Research is uniquely positioned to deliver insights that cater to international and local client needs. “Our team’s deep understanding of the local business market, coupled with a strong emphasis on identifying critical drivers of value, allows us to maintain a competitive edge,” said Managing Partner Asif Khan. “Collaborating with Andersen Global strengthens our ability to deliver independent, globall

DDC Announces Strategy to Create Bitcoin Reserves and Appoints Crypto Asset Expert Alex Yang as Strategic Advisor18.3.2025 15:14:00 EET | Press release

DDC Enterprise, Ltd. (NYSEAM: DDC), (“DayDayCook,” “DDC,” or the “Company”), a leading multi-brand Asian consumer food company, today announced a transformative initiative to adopt Bitcoin as part of its treasury reserves, alongside an announcement that brings seasoned Web3 and Crypto Assets Management Expert Alex Yang to DDC as Strategic Advisor. An investor group will inject up to 100 BTC in exchange for DDC Class A Ordinary shares at a range of $0.50 to $1.25 per share, representing a 100% to 400% premium to recent trading levels. Strategic Alignment with Institutional Confidence “This partnership is a testament to the shared conviction in DDC’s future and the value of Bitcoin and potentially other crypto currencies as a strategic asset,” said Ms. Norma Chu, Chairwoman and CEO of DDC Enterprise. “This strategic decision to launch a bitcoin reserve not only diversifies our balance sheet but also secures a premium-priced equity agreement that reflects our partner’s belief in our long-

Qualcomm Increases Quarterly Cash Dividend18.3.2025 15:00:00 EET | Press release

Qualcomm Incorporated (NASDAQ: QCOM) today announced that its Board of Directors has approved an increase in the Company’s quarterly cash dividend from $0.85 to $0.89 per share of common stock. This dividend increase will be effective for quarterly dividends payable after March 27, 2025, and will raise the annualized dividend payout to $3.56 per share of common stock. Cristiano Amon, President and CEO of Qualcomm Incorporated, said, “We are pleased to announce an increase in our quarterly dividend. Given our long-term growth expectations we provided at our 2024 Investor Day, we remain committed to returning capital to stockholders through a balanced capital return policy, including a baseline of anti-dilutive stock repurchases, and an annualized dividend target of low- to mid-single-digit percentage growth.” About Qualcomm Qualcomm relentlessly innovates to deliver intelligent computing everywhere, helping the world tackle some of its most important challenges. Building on our 40 years

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye